From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,044,054 shares, representing 7.74% for $24.7 million under the buyback announced on November 6, 2014.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.94 USD | -0.05% |
|
0.00% | +15.41% |
Jun. 10 | Surmodics Signs Group Purchasing Deal With Premier | MT |
Jun. 10 | Surmodics, Inc. Receives Thrombectomy Products Agreement with Premier, Inc | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.41% | 598M | |
-4.69% | 184B | |
-2.94% | 103B | |
-5.00% | 67.59B | |
+15.76% | 46.93B | |
-8.62% | 43.87B | |
+8.28% | 41.2B | |
+17.34% | 30.47B | |
+13.59% | 24.16B | |
-7.46% | 23.57B |
- Stock Market
- Equities
- SRDX Stock
- News Surmodics, Inc.
- Tranche Update on Surmodics, Inc.'s Equity Buyback Plan announced on November 6, 2014.